Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina

<div>Electrocardiography findings. (a) ST-segment elevation in leads V2–4 during a heart attack. (b) After lingual nitroglycerin therapy, ST-segment elevations resolved.</div>

Case Reports in Cardiology

fig2

Figure 2

Figure 2: Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina 